We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current SES market cap is 20.88M. The company's latest EPS is AUD -0.0113 and P/E is -2.65.
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 20.85M | 21.04M | 30.08M | 31.04M | 22.84M |
| Operating Income | -3.86M | -885k | 673k | -2.72M | -5.57M |
| Net Income | -4.17M | -1.19M | 2.59M | -3.09M | -6.75M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 14.56M | 15.75M | 33.77M | 33.22M | 27.96M |
| Total Liabilities | 4.57M | 4.38M | 4.55M | 6.55M | 4.83M |
| Total Equity | 10M | 11.38M | 29.22M | 26.67M | 23.13M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -3.12M | -650k | -4.7M | -4.06M | 2.02M |
| Investing | 2.48M | -493k | -1.15M | -2.44M | -639k |
| Financing | 1.58M | 1.15M | 14.39M | -747k | 2.94M |
| Market Cap | 20.88M |
| Price to Earnings Ratio | -2.65 |
| Price to Sales Ratio | 0.78 |
| Price to Cash Ratio | 2.13 |
| Price to Book Ratio | 0.77 |
| Dividend Yield | - |
| Shares Outstanding | 596.61M |
| Average Volume (1 week) | 122.56k |
| Average Volume (1 Month) | 126.04k |
| 52 Week Change | -46.97% |
| 52 Week High | 0.07 |
| 52 Week Low | 0.03 |
| Spread (Intraday) | 0 (2.7%) |
| Company Name | SECOS Group Limited |
| Address |
unit 1 melbourne, victoria 3149 |
| Website | https://wwwsecosgroup.com.au |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
